Materias dentro de su búsqueda.
Mostrando 61 - 80 Resultados de 312 Para Buscar '"Gavi"', tiempo de consulta: 0.18s Limitar resultados
  1. 61
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Seroprevalence and Genotype Diversity of Hepatitis C Virus in the Caribbean—A Review
  2. 62
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Relative efficiency of demand creation strategies to increase voluntary medical male circumcision uptake: a study conducted as part of a randomised controlled trial in Zimbabwe
  3. 63
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficiency in PrEP Delivery: Estimating the Annual Costs of Oral PrEP in Zimbabwe
  4. 64
    por da Costa-Rocha, Ismael Artur, Machado, Ketty Lysie Libardi Lira, Campi-Azevedo, Ana Carolina, Teixeira-Carvalho, Andréa, Peruhype-Magalhães, Vanessa, de Lima, Sheila Maria Barbosa, Miranda, Emily Hime, Trindade, Gisela Freitas, Casagrande, Thays Zanon, Miyamoto, Samira Tatiyama, Deotti, Sávio Carvalho, Barbosa, Rafaela Villa Real, Rocha, Priscila Costa Martins, Serrano, Erica Vieira, Dinis, Valquiria Garcia, Gouvêa, Sônia Alves, Gavi, Maria Bernadete Renoldi de Oliveira, da Silva, Lidia Balarini, Duque, Ruben Horst, Gianordoli, Ana Paula Espíndula, Bissoli, Maria de Fatima, Gouvea, Maria da Penha Gomes, Pinto-Neto, Lauro Ferreira da Silva, Burian, Ana Paula Neves, Fantinato, Francieli Fontana Sutile Tardetti, Pileggi, Gecilmara Salviato, da Mota, Licia Maria Henrique, Valim, Valéria, Martins-Filho, Olindo Assis
    Publicado 2021
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination
  5. 65
    por Valim, Valéria, Machado, Ketty Lysie Libardi Lira, Miyamoto, Samira Tatiyama, Pinto, Arthur Dalmaso, Rocha, Priscila Costa Martins, Serrano, Erica Vieira, Dinis, Valquiria Garcia, Gouvêa, Sônia Alves, Dias, João Gabriel Fragoso, Campi-Azevedo, Ana Carolina, Teixeira-Carvalho, Andréa, Peruhype-Magalhães, Vanessa, da Costa-Rocha, Ismael Artur, de Lima, Sheila Maria Barbosa, Miranda, Emily Hime, Trindade, Gisela Freitas, Maia, Maria de Lourdes de Sousa, Gavi, Maria Bernadete Renoldi de Oliveira, da Silva, Lidia Balarini, Duque, Ruben Horst, Gianordoli, Ana Paula Espíndula, Casagrande, Thays Zanon, Oliveira, Karine Gadioli, Moura, Bruna Costa da Mata, Nicole-Batista, Fernanda, Rodrigues, Luiza Correa, Clemente, Thalles Brandão, Magalhães, Enan Sales, Bissoli, Maria de Fatima, Gouvea, Maria da Penha Gomes, Pinto-Neto, Lauro Ferreira da Silva, Costa, Carolina Zorzanelli, Giovelli, Raquel Altoé, Brandão, Leticia Resende, Polito, Elizandra Tomazela Laurenti, Koehlert, Ingrid de Oliveira, Borjaille, Brunela Passos, Pereira, Daniela Bergamim, Dias, Laiza Hombre, Merlo, Daniela Linhares, Genelhu, Luiz Fellipe Favoreto, Pretti, Flavia Zon, Giacomin, Maryella dos Santos, Burian, Ana Paula Neves, Fantinato, Francieli Fontana Sutile Tardetti, Pileggi, Gecilmara Salviato, da Mota, Lícia Maria Henrique, Martins-Filho, Olindo Assis
    Publicado 2020
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study
  6. 66
    “…BACKGROUND: When countries reach the middle-income threshold, many multilateral donors, including Gavi, the Vaccine Alliance (Gavi), begin to withdraw their official development assistance (ODA), known as graduation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Strategic donor behaviour and country vulnerability in health aid transitions
  7. 67
    “…As a funder of vaccines, Gavi, The Vaccine Alliance (Gavi) has goals for its market shaping efforts, achieved through a strategy developed and implemented by the Gavi Secretariat, UNICEF, the World Health Organization (WHO) and the Bill & Melinda Gates Foundation (BMGF). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Shaping markets to benefit global health – A 15-year history and lessons learned from the pentavalent vaccine market
  8. 68
    “…As one of Gavi, the Vaccine Alliance (previously the Global Alliance for Vaccines and Immunization), graduating countries, Indonesia is still eligible to access Gavi price for PCV13, PCV10 A and B. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia
  9. 69
    “…Countries in the WHO African region had the greatest proportion of introductions (37%, 31/84) by December 2016 and a great majority of these (77%, 24/31) were supported by new vaccine introduction (NVI) grants from Gavi. Almost half (48%) of global introductions were in low and lower-middle income Gavi-eligible and Gavi-graduating countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Global rotavirus vaccine introductions and coverage: 2006 – 2016
  10. 70
    “…While nation states are key to rabies elimination, the importance of Gavi’s role cannot be understated. Unlike any other actor, Gavi can directly address an otherwise intractable market failure in the inadequate supply of rabies PEP. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A social justice perspective on access to human rabies vaccines
  11. 71
    “…Vaccine program costs were approximately 37 million USD for all vaccines with Gavi support. Without cross-protection, CECOLIN was dominant, being cost-effective with or without Gavi support. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study
  12. 72
    “…Equity monitoring is a priority for Gavi, the Vaccine Alliance, and for those implementing The 2030 agenda for sustainable development. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An equity dashboard to monitor vaccination coverage
  13. 73
    “…In November 2013, the Board of Gavi (the Vaccine Alliance) approved the provision of support for IPV introduction in the 72 Gavi-eligible countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Exceptional Financial Support for Introduction of Inactivated Polio Vaccine in Middle-Income Countries
  14. 74
    “…In this era of automated laboratory procedures, vitrification was made semi-automatic by using the GAVI(TM) system. CASE PRESENTATION: Donor oocytes were initially vitrified using the GAVI(TM) system. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The First Livebirth Using Warmed Oocytes by a Semi-Automated Vitrification Procedure
  15. 75
    “…To address these challenges, the international community came together and formed the Global Alliance for Vaccines Initiative (GAVI). Sixteen years after the formation of GAVI, we see evidence of a healthier global vaccine landscape. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Exploring the Case for a Global Alliance for Medical Diagnostics Initiative
  16. 76
    “…The introduction of these vaccines during the first phase of GAVI's operations demonstrated considerable variability. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Factors Affecting the Introduction of New Vaccines to Poor Nations: A Comparative Study of the Haemophilus influenzae Type B and Hepatitis B Vaccines
  17. 77
    “…We further identified countries that fulfill the two GAVI Alliance eligibility criteria to support nationwide HPV vaccination. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review
  18. 78
    “…BACKGROUND: Introduction of new vaccines in low- and lower middle-income countries has accelerated since Gavi, the Vaccine Alliance was established in 2000. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
  19. 79
    “…Even in a low mortality setting with no Gavi subsidy, rotavirus vaccination would be cost-effective. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact and cost-effectiveness of rotavirus vaccination in Bangladesh
  20. 80
    “…Afghanistan has applied for Gavi support to introduce rotavirus vaccination nationally. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan
Herramientas de búsqueda: RSS